Ultragenyx, Regeneron, Merck, Moderna: Readout Newsletter

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk more about Merck and Moderna’s potentially field-changing cancer vaccine, see a couple FDA approvals, and learn more about the new FDA commissioner nominee. Plus, brain organoids have stayed alive — and continue…

Ultragenyx, Regeneron, Merck, Moderna: Readout Newsletter

LONDON HAS FALLEN – Egypt Independent

I studied in London during 1970s amidst the IRA bombings – a time when the government encouraged you to conserve water and do joint showering. It was a tough era and I remember walking almost daily from Queensway to Houghton Street to the London School of Economics in WC2 and back as the underground received…

Hormone Therapy Is Still Not a Dementia Prevention Tool Under Current Guidance Despite New Autopsy Findings

A woman who read that estrogen-only hormone therapy was associated with fewer Alzheimer’s hallmarks in autopsied brains may now be asking her clinician whether she should start it. The answer available in official guidance has not changed, and understanding why is more useful than the study headline. Four weeks before those findings were published, the…